Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 19

1.

Optimization and Validation of HS-SPME-GCMS Method for Determination of Multifumigant Residues in Grain, Oilseeds, Nuts, and Dry Fruit.

Du X, Zhang W, Liu B, Liu T, Xiao Y, Taniguchi M, Ren Y.

J AOAC Int. 2019 May 16. doi: 10.5740/jaoacint.18-0093. [Epub ahead of print]

PMID:
31097055
2.

Cold Response of the Mediterranean Fruit Fly (Ceratitis capitata) on a Lab Diet.

Al-Behadili FJM, Bilgi V, Li J, Wang P, Taniguchi M, Agarwal M, Ren Y, Xu W.

Insects. 2019 Feb 3;10(2). pii: E48. doi: 10.3390/insects10020048.

3.

Coffee Intake and Liver Enzyme Association in Korean Immigrants and Japanese: A Comprehensive Cross-Sectional Study.

Kim SK, Shin MH, Sugimoto K, Kim SR, Imoto S, Kim KI, Taniguchi M, Oh HK, Yano Y, Hayashi Y, Kudo M.

Dig Dis. 2016;34(6):665-670. Epub 2016 Oct 17.

PMID:
27750235
4.

Seroepidemiology of hepatitis a infection in northeastern china, Korea, and Japan.

Yun H, Lee HJ, Yoon Y, Kim K, Kim S, Shin MH, Taniguchi M, Kim SR, Kim MK.

Osong Public Health Res Perspect. 2012 Mar;3(1):31-5. doi: 10.1016/j.phrp.2012.01.005.

5.

Comparison of prevalence of metabolic syndrome between korean emigrants and host country residents in Japan and china-the korean emigrant study.

Shin MH, Kim MK, Li ZM, Oh HK, Kim SR, Taniguchi M, Fang J.

Epidemiol Health. 2010 May 7;32:e2010005. doi: 10.4178/epih/e2010005.

6.

Outcome and early viral dynamics with viral mutation in PEG-IFN/RBV therapy for chronic hepatitis in patients with high viral loads of serum HCV RNA genotype 1b.

Sasase N, Kim SR, Kudo M, Kim KI, Taniguchi M, Imoto S, Mita K, Hayashi Y, Shoji I, El-Shamy A, Hotta H.

Intervirology. 2010;53(1):49-54. doi: 10.1159/000252784. Epub 2010 Jan 5.

7.

Double-filtration plasmapheresis plus IFN for HCV-1b patients with non-sustained virological response to previous combination therapy: early viral dynamics.

Kim SR, Imoto S, Kudo M, Mita K, Taniguchi M, Kim KI, Sasase N, Shoji I, Nagano-Fujii M, El-Shamy A, Hotta H, Nagai T, Nagata Y, Hayashi Y.

Intervirology. 2010;53(1):44-8. doi: 10.1159/000252783. Epub 2010 Jan 5.

8.

Well-differentiated hepatocellular carcinoma smaller than 15 mm in diameter totally eradicated with percutaneous ethanol injection instead of radiofrequency ablation.

Kim SR, Imoto S, Nakajima T, Ando K, Mita K, Taniguchi M, Sasase N, Matsuoka T, Kudo M, Hayashi Y.

Hepatol Int. 2009 Jun;3(2):411-5. doi: 10.1007/s12072-009-9128-z. Epub 2009 Mar 21.

9.

Epidemiology of hepatitis E in Northeastern China, South Korea and Japan.

Taniguchi M, Kim SR, Mishiro S, Takahashi K, Shin MH, Yun H, Park MS, Li ZM, Kim MK, Fang J, Hayashi Y.

J Infect. 2009 Mar;58(3):232-7. doi: 10.1016/j.jinf.2009.01.011. Epub 2009 Feb 26.

PMID:
19249101
10.

Pegylated interferon plus ribavirin combination therapy for chronic hepatitis C with high viral load of serum hepatitis C virus RNA, genotype 1b, discontinued on attaining sustained virological response at week 16 after onset of acute pancreatitis.

Kim SR, Imoto S, Mita K, Taniguchi M, Sasase N, Muramatsu A, Kudo M, Kitai S, El-Shamy A, Hotta H, Hayashi Y.

Digestion. 2009;79(1):36-9. doi: 10.1159/000203639. Epub 2009 Feb 25.

PMID:
19246919
11.

Acute Pancreatitis Associated with Pegylated Interferon and Ribavirin Treatment of Chronic Hepatitis C, Genotype 1b with High Viral Load.

Ando K, Kim SR, Imoto S, Nakajima T, Mita K, Fukuda K, Taniguchi M, Sasase N, Muramatsu A, Matsuoka T, Kudo M, Hayashi Y.

Case Rep Gastroenterol. 2009 Nov 21;3(3):372-376.

12.

Focal nodular hyperplasia-like lesion with venous washout in alcoholic liver cirrhosis.

Kim SR, Imoto S, Ikawa H, Ando K, Mita K, Shimizu K, Taniguchi M, Sasase N, Matsuoka T, Kudo M, Kawada N, Hayashi Y.

Intern Med. 2008;47(21):1899-903. Epub 2008 Nov 4.

13.

Usefulness of a new immunoradiometric assay of HCV core antigen to predict virological response during PEG-IFN/RBV combination therapy for chronic hepatitis with high viral load of serum HCV RNA genotype 1b.

Sasase N, Kim SR, Kim KI, Taniguchi M, Imoto S, Mita K, Hotta H, Shouji I, El-Shamy A, Kawada N, Kudo M, Hayashi Y.

Intervirology. 2008;51 Suppl 1:70-5. doi: 10.1159/000122601. Epub 2008 Jun 10.

PMID:
18544951
14.

Long-term outcome of percutaneous ethanol injection therapy for minimum-sized hepatocellular carcinoma.

Taniguchi M, Kim SR, Imoto S, Ikawa H, Ando K, Mita K, Fuki S, Sasase N, Matsuoka T, Kudo M, Hayashi Y.

World J Gastroenterol. 2008 Apr 7;14(13):1997-2002.

15.

Case of adult genotype C HBV carrier after acute hepatitis B, losing HBsAg and acquiring HBsAb after IFN and lamivudine treatment.

Kim SR, Imoto S, Fuki S, Taniguchi M, Kim KI, Mita K, Ando K, Nakajima T, Hong HS, Fukuda K, Sasase N, Kudo M, Hayashi Y.

Hepatol Res. 2006 Oct;36(2):149-52. Epub 2006 Aug 1.

PMID:
16884945
16.

Well-differentiated HCC manifesting hyperattenuation on CT during arterial portography.

Kim SR, Kim KI, Maekawa Y, Imoto S, Ninomiya T, Mita K, Ando K, Fukuda K, Fuki S, Kudo M, Matsuoka T, Sasase N, Taniguchi M, Hayashi Y.

Hepatogastroenterology. 2005 Sep-Oct;52(65):1559-62.

PMID:
16201119
17.

Primary sclerosing cholangitis and hepatitis C virus infection.

Kim SR, Imoto S, Taniguchi M, Kim KI, Sasase N, Matsuoka T, Maekawa Y, Ninomiya T, Ando K, Mita K, Fuki S, Koterazawa T, Fukuda K, Kudo M, Sakamoto H, Hayashi Y.

Intervirology. 2005;48(4):268-72.

PMID:
15920352
18.

Effects of physical training on heat loss responses of young women to passive heating in relation to menstrual cycle.

Kuwahara T, Inoue Y, Taniguchi M, Ogura Y, Ueda H, Kondo N.

Eur J Appl Physiol. 2005 Jul;94(4):376-85. Epub 2005 Apr 28.

PMID:
15864636
19.

Prediction of efficacy of interferon treatment of chronic hepatitis C and occurrence of HCC after interferon treatment by a new classification.

Kim KI, Sasase N, Taniguchi M, Mita K, Kim SR, Tanaka K, Hayashi Y.

Intervirology. 2005;48(1):52-8.

PMID:
15785090

Supplemental Content

Loading ...
Support Center